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Abstract: Costs and benefits of the immune response have attracted considerable attention 
in the last years among evolutionary biologists. Given the cost of parasitism, natural 
selection should favor individuals with the most effective immune defenses. Nevertheless, 
there exists huge variation in the expression of immune effectors among individuals. To 
explain this apparent paradox, it has been suggested that an over-reactive immune system 
might be too costly, both in terms of metabolic resources and risks of immune-mediated 
diseases, setting a limit to the investment into immune defenses. Here, we argue that this 
view neglects one important aspect of the interaction: the role played by evolving 
pathogens. We suggest that taking into account the co-evolutionary interactions between 
the host immune system and the parasitic strategies to overcome the immune response 
might provide a better picture of the selective pressures that shape the evolution of immune 
functioning. Integrating parasitic strategies of host exploitation can also contribute to 
understand the seemingly contradictory results that infection can enhance, but also protect 
from, autoimmune diseases. In the last decades, the incidence of autoimmune disorders has 
dramatically increased in wealthy countries of the northern hemisphere with a concomitant 
decrease of most parasitic infections. Experimental work on model organisms has shown 
that this pattern may be due to the protective role of certain parasites (i.e., helminths) that 
rely on the immunosuppression of hosts for their persistence. Interestingly, although  
parasite-induced immunosuppression can protect against autoimmunity, it can obviously favor 
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the spread of other infections. Therefore, we need to think about the evolution of the 
immune system using a multidimensional trade-off involving immunoprotection, 
immunopathology and the parasitic strategies to escape the immune response. 
Keywords: autoimmunity; immunosuppression; immune evasion; Treg cells; immune 
regulation; hygiene hypothesis; molecular mimicry 
 
1. Introduction 
In the last decade, evolutionary biologists interested in the ecology and evolution of host-parasite 
interactions and the evolution of parasite virulence have become more and more aware of the 
importance of immune defenses for the evolution of a number of host and parasite traits [1–5]. This 
has lead to the emergence of a novel discipline named “ecological immunology” [6]. A central tenet of 
this discipline is that maximal investment into immune defenses might not be synonymous of optimal 
strategy, because maximal defenses do not necessarily translate into maximal fitness [7]. The reason 
for this is that investment into immune defenses can be afforded at the expense of investment into 
other fitness-related functions, which generates trade-offs between traits [8,9]. This sets a clear analogy 
between immune defenses and any other life history trait. As maximal investment into reproduction 
might not be an optimal strategy for an iteroparous species, because of the survival costs of breeding 
effort [10], maximal investment into immune defenses might come at cost of investment into other life 
history traits, such as growth rate, reproductive output or other physiological functions related to  
self-maintenance [11,12]. The general paradigm that has been adopted by ecological immunology 
studies is that these trade-offs are generated because immune defenses are costly in terms of energy 
and/or limited resources [13]. This paradigm has attracted considerable attention, and several studies 
have attempted to assess the energetic cost of immune activation [14–20]. Although there is a general 
consensus on the idea that the immune response requires metabolic resources, the question whether the 
magnitude of the cost is sufficient to force the emergence of trade-offs is still debated [15,19,20]. 
However, immunity does not entail only energetic costs. The immune system is often depicted as a 
two-edged sword, where one edge protects against infectious diseases and the other edge exposes to 
the risk of misdirected immune reaction. This phenomenon is generally called immunopathology and 
illustrates the process of immune system attacking the structures of the host. Immune-mediated 
diseases can be classified according to two main modes of action: antigen-specific and  
antigen-nonspecific [21]. An erroneous recognition of the antigen that triggers the immune response 
can induce substantial costs for the host, depending on the molecule/organ that is the target of the 
misoriented immune reaction. A classic example of immune-mediated diseases is type1 diabetes 
mellitus (T1DM), where T-cells and antibodies progressively target and destroy  cells in the islets of 
Langerhans in the pancreas and the hormone these cells secrete (i.e., insulin) [22]. Antigen-nonspecific 
immunopathology arises as a collateral undesirable effect of an over-reacting immune response against 
an invading parasite, for instance, during chronic inflammation. Immunopathology is actually thought 
to be one of the principal determinants of the most serious symptoms induced by some human 
infectious diseases, such as tuberculosis, malaria or the highly pathogenic influenza virus [23,24]. 
Similarly, studies on animal models, both vertebrates and invertebrates, have provided a wealthy of 
evidence on the dual effect of the immune system and the cost of immunopathology (i.e., [25,26]). 
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Since an over-reacting immune response—or a response failing to make a distinction between self 
and non-self―potentially generates substantial fitness costs [27,28], one should expect natural 
selection to have favored the evolution of regulation mechanisms that prevent the system to get out of 
control. Indeed, the immune system is characterized by a series of checkpoints and filters that block 
and prevent the spread of autoreactive cells and shape immunological tolerance (i.e., the nonreactivity 
of the immune system to a given antigen). This regulation includes central (the negative selection of 
self-reactive lymphocytes in the thymus) and peripheral mechanisms (anergy, activation of regulatory 
T-cells) [22]. In spite of this regulatory network, autoimmune disorders are common diseases. From an 
evolutionary perspective this might seem puzzling, since natural selection should progressively favor 
individuals with the most effectively regulated immune system. In this article, we suggest that the 
maintenance of immunopathology by natural selection might be due to the combined effect of two 
factors: (i) the trade-off between immunoprotection and immunopathology and (ii) the strategies 
adopted by parasites to escape and manipulate the host immune response.  
We will first briefly review the principal effectors that regulate the immune response, and we will 
illustrate the dilemma faced by the immune system between protection and over-reaction; then, we will 
see how parasitic strategies of immune evasion can alter up- and down-regulatory mechanisms and, as 
such, exacerbate or protect hosts from immunopathology. Finally, we will stress that all the empirical 
results that we discuss here come from studies on humans and model organisms. The relevance of 
what is going on in modern human societies and congenic strains of mice with respect to natural 
conditions is open to discussion.  
2. The Regulation of the Immune System 
The immune system is a sophisticated and complex weapon that has evolved to destroy invading 
pathogens [29]. Benefits of having a well-performing immune system are clearly shown by the 
pathologies associated with congenital and/or acquired immunodeficiencies. The protective function of 
the immune system resides in the capacity of immune cells to discriminate between self and non-self 
antigens. Major histocompatibility complex (MHC) molecules expressed on the surface of all nucleated 
cells (class I), and “professional” antigen presenting cells (class II) are an essential tool for the recognition 
of non-self antigens. These proteins bind to antigenic peptides and present them to T-cells.  
CD4
+
 T-cells play a pivotal role in the polarization of the immune response. Following a microbial 
stimulus, naive CD4
+
 T-cells differentiate into Th1, Th2 and Treg helper cells. These cells are characterized 
by the cytokines they produce. A Th1 response is characterized by the production of pro-inflammatory 
cytokines, such as gamma interferon (IFN-) and tumor necrosis factor alpha (TNF-), which activate 
cell-mediated reactions. The Th1 response is usually elicited by many intracellular pathogens. The Th2 
response is, on the contrary, characterized by the production of a different set of cytokines (IL-4, IL-5, 
IL-10, IL-13), which are responsible for immunoglobulin class switching and the inhibition of 
inflammation. Interestingly, cytokines of the Th1 phenotype tend to inhibit Th2 effector functions, 
whereas cytokines of the Th2 phenotype inhibit Th1 functions. Treg cells are characterized by the 
CD25
+
 receptor and account for 5-10% of peripheral CD4
+
 T-cells in mouse and humans. Treg cells 
contribute to ensure self-tolerance by suppressing autoreactive lymphocytes, mostly through contact or 
via the secretion of anti-inflammatory cytokines, such as IL-10 and transforming growth factor beta 
(TGF-[30–32]. 
Any dysfunction of the immune system exposes the host to several potential costs, such as an 
increased risk to contract an infection or suffer from an autoimmune disorder. This emphasizes the 
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need of control mechanisms that regulate the functioning of immune effectors [33]. Control 
mechanisms that prevent the spread of autoreactive T-cells operate in the thymus by the deletion of 
immature T-cells that recognize self-antigens and in peripheric organs by anergy, deletion by apoptosis 
and the action of the above mentioned Treg cells [34–37]. Whereas deletion of immature T-cells in the 
thymus limits the risk of antigen-specific immunopathology, mechanisms that operate in peripheric 
organs contribute to the control of both antigen-specific and antigen-nonspecific immunopathology. In 
the rest of this review, we will focus on the control mechanisms operating in peripheric organs.  
Much attention has been recently devoted to Treg cells as an essential component of the regulatory 
network that avoids the over expression of the immune response. The paramount role of Treg 
lymphocytes has been established with a series of elegant experiments. Mutation in the gene encoding 
the transcription factor Foxp3, which is required for Treg lymphocyte development, induces lethal 
autoimmunity [38]. Similarly, in vivo ablation of Treg cells produces catastrophic autoimmunity in both 
juvenile and adult mice [30]. 
Given that autoreactive T- and B-cells, as well as cells of the inflammatory response are part of the 
normal immune cell repertoire in healthy individuals, the key point to understand autoimmunity is to 
identify the factors that trigger these quiescent autoreactive cells to actively target host tissues and 
organs, in spite of the regulatory mechanisms. The occurrence of autoimmune diseases is not a rare 
event, in particular in western societies, where the incidence of some autoimmune disorders has 
dramatically increased in the last decades [39–42]. Then, why natural selection has not succeeded to 
eliminate immune-related diseases or keep them at a low rate? 
3. Immune Evasion, Immune Regulation and Immunopathology 
If pathogens were static entities, the regulatory mechanisms that avoid the overexpression of the 
immune response might be enough to ensure the optimal functioning of the system. However, 
pathogens are evolving entities and, as such, they do respond to the selection pressures exerted by the 
immune system. One might even think of a successful parasite as a parasite that has escaped the 
immune response of the host, at least until transmission to a novel host. Immune evasion is a common 
strategy of parasitic organisms, including microparasites (viruses, bacteria and protozoa), as well as 
metazoan helminths [43–48]. Immune evasion can take several forms, as hiding from and suppressing 
the immune response [49]. Therefore, parasite interference with the normal immune response poses a 
novel problem to the immune system, since parasite manipulation of the immune response is likely to 
alter the balance that exists between immunoprotection and immunopathology (Figure 1). 
3.1. Immune Suppression 
Although immune evasion has been selected to favor parasite establishment within the host, it is likely 
that some particular strategies adopted to escape the immune response might paradoxically be beneficial 
also for the hosts [42,50]. In particular, parasitic strategies that dampen immune reactivity, while being 
clearly favorable for the parasite, could also protect the host from immunopathology [21,51–55]. Is 
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Figure 1. A schematic view of the costs and benefits of infection-induced immune 
activation. Although immune mediated parasite clearance has evident benefits in terms of 
parasite resistance, it can also induce costs in terms of immunopathology. Similarly, 
although failure to clear the parasite and the persistent infection that ensues are usually 
considered to be costly for the host, it can also generate benefits in terms of protection 
from autoimmunity. 
 
Helminths are multicellular worm parasites that usually occur with high prevalence in natural 
populations. In many instances, the infection persists in face of the host immune response, suggesting 
that helminths have evolved effective strategies of immune evasion and suppression [42,56]. Direct 
experimental evidence for the role played by helminths in the protection from immunopathology comes 
from several studies involving different helminth parasites of mice [57,58]. For instance, experimental 
infection with the trematode Schistosoma mansoni prevents the development of T1DM in non-obese 
diabetic (NOD) mice [59], as well as allergic encephalomyelitis [60] and Grave’s thyroiditis [61]. 
Intestinal nematodes, such as the murine parasite Heligsomoides polygyrus, have also been shown to 
have immunomodulator properties. Mice with chronic H. polygyrus infections are less likely to 
develop airway inflammation [62] and allergy [63]. 
Given that helminths induce a Th2 type response, the protective role of such infections was first 
explained with the Th1/Th2 paradigm [64]. Th2 cytokines inhibit the Th1 effectors thought to be the 
principal cause of inflammatory and immune-mediated diseases. Recently, however, evidence has 
accumulated showing the involvement of Treg cells [56]. In addition to helminths, other pathogens can also 
protect from autoimmune diseases by activating Treg cells [65]. For instance, Leishmania major [66,67], 
herpes simplex virus type 1 [68], murine leukemia virus [69] and certain strains of Plasmodium yoelii [70] 
have all been shown to escape the host immune system by activating Treg cells.  
Parasitic strategies to escape the immune response also involve dampening of inflammation, a 
major determinant of immunopathology. Some pathogens can secrete molecules that interfere with the 
signaling pathways triggering the inflammatory response, such as the Nuclear Factor kappaB (NF-kB) 
(a transcription factor that plays a key role in regulating the immune response to infection) or cytokine 
IL-10. Enterobacteria from the genus Yersinia produce a protease that downregulates the NF-kB 
signaling pathway [71]. A few intracellular pathogens (e.g., HIV, cytomegaloviruses, mycobacteria) 
can dampen the host immune response by inducing the production of the anti-inflammatory cytokine 
IL-10 by the host or by expressing a IL-10 homolog [72]. Interestingly, these pathogens likely benefit 
from the IL-10 driven immunosuppression, as well as by other mechanisms unrelated to the  
anti-inflammatory action of IL-10. For instance, IL-10 has been shown to increase the expression of 
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the CCR5 receptor, a major co-receptor for HIV-1 [73]. Similarly, cytomegalovirus-induced 
production of IL-10 interferes with the antigen-presentation pathway by downregulating MHC class II 
expression [74].  
Inducible nitric oxide synthase (iNOS) also plays a primordial role in inflammation and pathogen 
killing by producing RNS, such as nitric oxide (NO). Some pathogens have evolved a strategy to 
prevent the production of NO in macrophages by repressing or inhibiting iNOS gene expression [47]. 
For instance, Citrobacter rodentium, an intestinal parasite of mice, inhibits iNOS activity in the 
intestinal region, where the infection is localized, although the activity of the enzyme can be 
upregulated in other organs [75].  
To conclude, whereas, on one hand, immune suppression directly benefits the parasite to persist 
within the host and establish a chronic infection, the parasite-induced downregulation of the immune 
response can also be beneficial for the host in terms of reduced immunopathology risk, as illustrated 
by the clinical trials using nematode worms to cure Crohn’s disease and ulcerative colitis [76,77]. 
3.2. Molecular Mimicry 
As already said, immunopathology is often seen as an unavoidable cost of immune protection, 
something that harms the host, with no obvious benefit for the parasite. This might not always be true, 
since strategies of immune evasion that enhance parasite survival within the host can directly be 
responsible for the onset of immune disorders. Parasitic strategies to escape immune defenses can, 
therefore, protect from or exacerbate immunopathology [78] (Table 1). Molecular mimicry is one such 
mechanism that might favor the pathogen [79], while increasing the risk of autoimmune disorders. 
Molecular mimicry refers to the property of a given pathogen to share antigenic determinants with the 
host [80–83]. Pathogens that mimic host antigens can evade immunity, because self-tolerance 
mechanisms eliminate or anergize autoreactive T-cells. However, depending on the degree of 
structural resemblance between parasite and host epitopes and/or the repeated activation of 
autoreactive T-cells during infection, mimicry can stimulate the destruction of host tissues. Herpes 
simplex virus 1-infected mice develop herpes stroma keratitis, because autoreactive T-cells attack 
corneal tissue. The reason for this autoimmune reaction is a cross-reactive epitope between the virus 
(the UL6 protein) and a host corneal protein. Strong support to the view that stroma keratitis is due to 
molecular mimicry comes from experiments where viruses lacking the UL6 protein or expressing an 
altered mimic epitope are inoculated [84]. In this case, mice do not develop the autoimmune disorder. 
Another example of immunopathology induced by molecular mimicry is provided by  
Guillain-Barré syndrome, an autoimmune disease affecting the nervous system that is usually induced 
by infection with the bacterium Campylobacter jejuni [85,86]. Indeed, it has been shown that C. jejuni 
expresses a lipopolysaccharide that imitates gangliosides found in peripheral nerves [87]. 
Although molecular mimicry is an appealing hypothesis to account for the persistence of 
immunopathology by natural selection, we should emphasize that, since the concept was put forward 
by Damian [79], there is very few direct evidence showing that molecular mimicry has evolved as a 
strategy to allow the persistence of the parasite within the host. Theoretical and empirical work 
exploring the fitness consequences of molecular mimicry is definitely needed [88]. Herpes simplex 
virus 1 offers the possibility to explore the fitness consequences of molecular mimicry, since one 
should be able to compare the fitness of the strains expressing the UL6 protein vs. those that do not or 
that express a slightly altered epitope.  
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Table 1. A non-exhaustive list of parasites (viruses, bacteria, protozoa and helminths) that 
have been reported to protect and/or induce immunopathology. Only experimental evidence 
is reported here. IBD = Inflammatory bowel disease; T1DM = Type 1 diabetes mellitus. 
Parasite Protection Exacerbation Ref. 
    
Viruses    
Influenza A virus  Allergy [89] 
Influenza A virus  Airway responsiveness [90] 
Respiratory Syncytial Virus  Airway hyper-reactivity [91] 
Respiratory Syncytial Virus Asthma  [92] 
Respiratory Syncytial Virus  Allergy [93] 
B3 Coxsackie virus  Myocarditis [94] 
B3 Coxsackie virus  T1DM [94] 
Rubella virus   T1DM [94] 
Rhinovirus  Allergy [95] 
Mouse hepatitis virus T1DM  [96] 
Mouse adenovirus type 1  Encephalomyelitis [25] 
Herpes simplex virus   Keratitis [84] 
    
Bacteria    
Mycobacterium bovis Encephalomyelitis  [97] 
Mycobacterium bovis Multiple sclerosis  [98] 
Mycobacterium bovis T1DM  [99] 
Mycobacterium tuberculosis  Adjuvant arthritis [100] 
Mycobacterium avium T1DM  [101] 
Mycobacterium avium Systemic lupus erythematosus  [102] 
Mycobacterium vaccae Allergy  [103] 
Salmonella typhimurium T1DM  [54] 
Chlamydia trachomatis Allergy  [104] 
Borrellia burgdorferi  Lyme arthritis [105] 
Bordetella pertussis  Allergy [106] 
Bordetella pertussis Encephalomyelitis  [107] 
Mycoplasma pneumoniae  Airway hyper-reactivity [108] 
Staphylococcus aureus  Allergy [95] 
Streptococcus sanguinis Collagen-induced arthritis  [109] 
Streptococcus A  Rheumatic heart disease [110] 
Streptococcus pyogenes  Rheumatic fever [111] 
Helicobacter pylori  Autoimmune gastritis [81] 
Campylobacter jejuni   Guillain-Barré syndrome [85] 
    
Protozoa    
Trypanosoma cruzii  Chaga’s disease [94] 
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Table 1. Cont. 
Parasite Protection Exacerbation Ref. 
Helminths    
Hymenolepis diminuta Colitis  [113] 
Heligmosomoides polygyrus IBD  [114] 
Schistosoma mansoni T1DM  [115] 
Schistosoma mansoni T1DM  [59] 
Schistosoma mansoni Colitis  [116] 
Schistosoma mansoni Encephalomyelitis  [60] 
Schistosoma mansoni Hyperthyroidism  [61] 
Trichuris suis Chron’s disease  [76] 
Trichuris suis IBD  [117] 
Trichinella spiralis Colitis  [118] 
Heligmosomoides polygyrus Allergy  [63] 
Nippostrongylus brasiliensis Allergy  [119] 
Nippostrongylus brasiliensis  Airway hyper-responsiveness [120] 
Strongyloides stercoralis Allergy  [121] 
Brugia malayi   Airway hyper-responsiveness [122] 
4. The “Educational” Role of Antigenic Exposure  
In addition to experimental work on animal models, the potential role played by the coevolutionary 
interactions between hosts and parasites in shaping patterns of immune regulation can also be apprised 
by the means of epidemiological studies. Epidemiological studies have clearly established the 
existence of a North-South cline in the prevalence of many autoimmune disorders and that in western, 
wealthy societies, the incidence of autoimmune diseases has increased tremendously in the last 
decades [123]. The high rate of increase [40], as well as the observation that migrating people acquire 
the profile risk of resident populations [39], concurs to exclude a major genetic determinism for these 
changes for most autoimmune disorders. Instead, it has been argued that the spatial and temporal 
variation in the occurrence of autoimmune disease could be linked to the variation in infection risk [124]. 
Early observations [125] showed that the occurrence of hay fever was negatively correlated with 
family size, possibly because late born children are exposed to a number of infectious diseases, carried 
by the first born child, that protect them from allergy. The idea underlying this so-called “hygiene 
hypothesis” is that the immune system has evolved and has been selected to cope with a diversity of 
surrounding parasitic organisms, each of which plays a role in the “education” (up-/down-regulation) 
of the immune response [126]. Human modern lifestyle has profoundly modified the interactions 
between the immune system and the pathogens currently faced. The eradication of helminths, the 
societal pressures to have clean habitats, the widespread use of antibiotics have, of course, greatly 
contributed to the improvement of human health, but perhaps we are now starting to pay the cost of 
these changes in terms of increased risk of autoimmune disease [41,53,57,123]. In line with this view, 
trial assays have been performed with the parasitic nematodes, Trichuris suis and Necator americanus, 
as “therapeutic” agents against inflammatory bowel disease and asthma [76,127]. 
Investigations of the “hygiene hypothesis” have also taken advantage of the particular environmental 
conditions encountered in farms to assess the role played by microbial exposure on both the innate and 
adaptive immune system and the subsequent risk to develop autoimmune disorders. Comparative 
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epidemiological studies conducted on groups of children living either in farms or in cities have 
provided a number of associations between exposure to lipopolysaccharide (LPS) of the cell wall of 
Gram-negative bacteria (farm children are exposed to higher dose of LPS in mattress dust) and 
allergen sensitization, hay fever and asthma [128–130]. These results suggest that living in a farm 
protects from some autoimmune disorders, although it must be stressed that the protective effect of 
LPS on future risk of allergy also depends on a number of factors, such as the timing of exposure 
(early vs. late exposure), the intensity of antigenic exposure, the nature of co-existing antigenic 
exposures and polymorphism of genes responsible for the immune response against LPS. 
Although there are several studies that have reported consistent epidemiological evidence for a 
positive association between a number of indices linked with infection risks [126,131], including 
socioeconomic factors [132,133], and the incidence of autoimmune disorders, we should keep in mind 
that such correlative work fails to establish a causal link between infection and protection from 
autoimmunity [134]. The role of confounding behavioral factors has been emphasized has a major 
challenge for these epidemiological surveys [135]. In spite of these criticisms, it should be noted that 
more direct, experimental evidence in support for the hygiene hypothesis comes from studies on 
animal models. The idea that living in too clean habitats might exacerbate the risk of autoimmunity 
receives support from the observation that animals raised in a germ-free environment develop autoimmune 
diseases faster and at higher rate than similar strains living in conventional environments [39]. 
5. Predicting the Evolutionary Consequences of Immune Evasion on Immune Regulation 
As emphasized above, the classic view on the evolution of immune defenses has been that 
conflicting demands of energy consuming functions shape the allocation of resources to each of them 
as to maximize fitness [6,136]. However, acknowledging the role of parasitic strategies to escape the 
immune system costs can broaden the focus from the resource allocation paradigm to the immune 
regulation hypothesis. If an hyperactive immune system can harm the host, the important trait likely to 
be under strong selection pressure is not only the total amount of energy/resources allocated to 
immune organs and cells, but also the effectiveness of the regulatory mechanisms that prevent the 
system to get out of control [137,138]. Bergstrom and Antia [33] have already discussed the 
importance of taking into account the need to avoid autoimmunity and to prevent parasite sabotage if 
we want have a better understanding of the complexity of the immune system.  
Low total investment into immune organs with a lack of regulatory effectors can be more harmful 
than a huge allocation into immune defenses with a very effective immune regulation. Focusing on the 
benefits and costs of immune regulation, one can figure out the optimal level of immune regulation. 
Benefits are likely to increase with the level of immune regulation, because regulation prevents 
immunopathology, until a plateau is reached (once the risk of immunopathology is nil, no further 
benefit is expected from more regulation). On the contrary, the cost function should be “U-shaped”, 
with a weakly regulated immune system exposing the host to high risk of immunopathology and a 
highly regulated immune system being unable to clear the infection. 
Parasites can, however, alter the shape of the cost/benefit functions. Parasites that protect from 
immunopathology reduce the cost of a weakly regulated immune system and should select for less 
regulated immune responses. Conversely, parasites that exacerbate autoimmunity should favor hosts 
with a highly regulated immune system.  
In a similar way, we might wonder how parasitic strategies that have evolved to face the host 
immune system—such as parasite induced immunosuppression—would affect host fitness [139]. 
Pathogens 2013, 2           
          
80 
While it is straightforward to think that parasite-induced immunosuppression is beneficial to the 
parasite, the effect on host fitness can be quite different, depending on the ratio between the cost of 
infection and the protection from immunopathology. When the cost of infection is low and/or the 
benefits in terms of protection from autoimmunity high (i.e., low values of the ratio between cost of 
infection and protection from autoimmunity), we can end up with a flat fitness function for the host. 
This could be the case for many helminth infections, where the parasites persist for long time within 
the host with little effect on host fitness. On the contrary, when the cost of infection is high and/or the 
protection from immunopathology marginal (i.e., high values of the ratio between cost of infection and 
protection from autoimmunity), the fitness function can be quite steep. 
Of course, this is a crude verbal representation of the possible relationships between parasitic 
strategies, immune regulation and host and parasite fitness, and quantitative models are needed to have 
more clear-cut predictions (see, for instance, [140,141]). Nevertheless, we believe that this verbal 
model shows the importance to broaden our view on the evolution of the immune response (i) by 
taking into consideration parasitic strategies and risk of immunopathology in addition to the classical 
energetic costs of immune functioning and (ii) by thinking about the evolution of the immune system 
using a multidimensional trade-off involving immunoprotection, immunopathology and the parasitic 
strategies to escape the immune response. 
Frank and Schmid-Hempel [142] provided an interesting hypothesis on the possible evolutionary 
consequences of immune evasion for parasite virulence. They drew a parallel with life history theory 
and showed that mechanisms that improve the survival of the pathogen within the host (by escaping 
the host immune response) have greater fitness sensitivity than mechanisms that incrementally alter 
transmission. This suggests that immune evasion mechanisms can result in increased pathogenic 
effects and affect virulence evolution. These ideas have further been developed by taking into account 
the time lag between the benefit of the immune evasion mechanism and the pathogenic effect (the 
longer the time lag, the strongest the selection for higher virulence) and the spread of the immune 
evasion mechanism throughout the host that should select against virulence (compared to a localized 
immune evasion mechanism) [48]. These theoretical models provide nice testable predictions that 
should elicit interest from experimentalists working on the evolution of parasite virulence. 
In addition to theoretical work, we suggest that artificial selection experiments and experimental 
coevolution studies might provide very relevant insights into the outcome of evolutionary “contest” 
between host immune protection/regulation and parasite immune evasion. For instance, using mice and 
parasites known to protect from or induce immunopathology, one should be able to measure the 
evolutionary response in terms of Treg cell numbers and production of anti-inflammatory cytokines 
(i.e., IL10, TGF-. 
As we mentioned above, some countries of the northern hemisphere have experienced a significant 
reduction of antigenic stress, due to the improved hygienic conditions, but a concomitant increase in 
the incidence of autoimmune diseases. Although we have to acknowledge the potential effect of 
confounding socio-economic factors, we might wonder whether these changes cannot be seen as a 
large scale experiment on the evolution of immune regulation under variable antigenic contexts.  
6. Limits 
Although ecological immunology has become a very fecund field of investigation, the fitness 
consequences of immune overreaction and how immune evasion interferes with optimal investment 
into the immune function have been less studied. There are, of course, several reasons for this, the 
Pathogens 2013, 2           
          
81 
most important being the difficulty to assess immunopathology (but, see [143–145]) and immune 
evasion in non-model, free-ranging species. Studying the evolutionary ecology of the immune 
response implies assessing the evolutionary forces and the environmental constraints that shape the 
investment into immune defenses, and this can only be done with outbred, free-ranging organisms that 
are exposed to a wide diversity of parasites and variable environmental conditions. 
We need to emphasize that all the evidence for immunopathology and associated risk-enhancing 
and risk-reducing effects of infection comes from studies carried out on humans and animal models. 
The extension of these results to natural populations of free-ranging organisms might, therefore, not be 
straightforward. Autoimmune disorders are multifactor, complex diseases that are triggered by several 
genetic and environmental factors, in an additive and, often, in an interactive way [146]. The timing of 
onset of immunopathology during an individual lifespan is obviously an important determinant of the 
fitness consequences of autoimmunity. Autoimmune disorders can be expressed during the early phase 
of development and can rapidly result in the death of the individual. Genetic variants that are 
associated with an accrued risk to develop an autoimmune disease [147] should be strongly  
counter-selected and should participate very little to the polymorphism observed at the population 
level. T1DM has a juvenile onset and is under the control of many genes in humans and rodents and 
was certainly lethal, until the discovery of effective treatment with insulin by Banting and Best ([148] 
in [40]). Contrary to the expectation that natural selection should remove these deleterious genetic 
variants from the present-day populations, these genes persist [147]. The reasons for this are unknown, 
but one might speculate that either the genes predisposing to diabetes or genes in linkage 
disequilibrium have been retained, because they convey a selective advantage. Alternatively, in line 
with the rationale of the “hygiene hypothesis”, infections “neutralized” the deleterious expression of 
such genes, until recently, when the eradication of most endemic infectious diseases has allowed the 
full expression of alleles predisposing to autoimmunity.  
At the other extreme of the gradient, some autoimmune disorders have a delayed timing of onset, 
with several years elapsed between the triggering effect (for instance, infection) and the development 
of the disease. If such delay is also necessary for the onset of autoimmune disorders in natural settings, 
the relevance of autoimmunity costs for the evolution of optimal immune functioning would be 
dramatically reduced, simply because, depending on the specific life history strategy, the 
immunopathology cost might concern a relatively small fraction of the population. Similarly, 
autoimmunity that is triggered by a dysfunction of the effectors of inflammation and that is typical of 
age-related diseases in humans [149] might be of little relevance for natural populations, because of 
the decline in the intensity of natural selection with age [150]. This obviously reduces the spectrum of 
potential autoimmune diseases that might play a significant evolutionary role in shaping the pattern of 
optimal allocation into immune defenses.  
Free-ranging organisms are exposed to a wide variety of pathogens and parasites, which makes it 
difficult to unambiguously identify the causative agent of an autoimmune disorder. Moreover, 
pathogens that simultaneously co-infect a host can interfere with the immune response mounted 
against other antigens. This has been fairly well demonstrated in several experimental infections of 
animal models [151,152]. For instance, it has been shown that latent infection with herpesviruses 
confers resistance to mice infected with two bacterial pathogens (Listeria monocytogenes and  
Yersinia pestis) [153]. After a series of lytic replication in a number of cell types, herpesvirus enters a 
dormant state in B-cells, macrophages and dendritic cells. Barton et al. [153] reported that latent 
herpesvirus infection induces a persistent activation of macrophages (including of those that are not 
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actually infected by the virus) with a subsequent elevated level of pro-inflammatory cytokines, such as 
IFN- and TNF-. Although a permanently enhanced secretion of pro-inflammatory cytokines can 
induce a benefit for the host in terms of resistance to bacterial infection, it can also expose it to risk of 
autoimmune disorders and cancer. Whether this type of immune-mediated interspecific interactions is 
widespread or rare under natural conditions is unknown, as is unknown whether these effects are the 
side-product of the interaction between the parasite and the host immune system or whether they are of 
any adaptive value for the parasite.  
These examples document the difficulty to establish an unequivocal and general causal link 
between infectious diseases, strategies that pathogens adopt to escape the host immune system and 
autoimmune disorders.  
7. Conclusions 
Ecological immunology is a relatively novel discipline that has its roots in a few seminal papers that 
have been published during the early 90s. In fifteen years, we have witnessed a growing interest from 
evolutionary biologists to the role played by the immune system for the ecology and evolution of  
host-parasite interactions. We believe that this early phase of the emergence of a new discipline is 
behind us, and we need now to go a step further by establishing a tighter link between the evolutionary 
approach and the knowledge of the immunological mechanisms underlying the control of the immune 
response in the face of rapidly evolving pathogens.  
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